BioMap, a life sciences AI company, has introduced xTrimoTox, a new model designed for predicting toxicity in molecules. This model utilizes a cell-world architecture and incorporates virtual dosing capabilities, aiming to enhance nonclinical drug safety assessments. BioMap reports that xTrimoTox achieved a mean ROC-AUC of 0.8598 on the Tox21 dataset, outperforming the DeepTox model. AI
IMPACT Enhances drug safety assessment capabilities with a new toxicity prediction model.
RANK_REASON This is a product release from a specialized AI company, not a frontier model release from a major lab.
Read on Mastodon — mastodon.social →
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →